Investor Overview

AFFY (Common Stock)

Exchange OTCQB
Price 0.10
Change(%) 0.000%
Volume 48,400

Data as of 07/28/14 3:15 PM ET Minimum 20 minute delay

Refresh Quote

Corporate Profile

Affymax, Inc. is a biopharmaceutical company committed to developing novel drugs to improve the treatment of serious and often life-threatening conditions. Our vision is to become a leader in the nephrology and specialty care space by delivering innovative therapeutic offerings to patients and healthcare providers.

Recent Releases

Transfer Agent

Computershare Trust Company, Inc.
350 Indiana Street, Suite 800, Golden, Colorado 80401
(800) 962-4284